Evidence map›Paper›PMID 32536652›Full record

ArticleInternal medicine (Tokyo, Japan)2020

Autologous Hematopoietic Recovery after Unrelated Umbilical Cord Blood Transplantation with Myeloablative Conditioning for Acute Myelogenous Leukemia.

Ayumi Gomyo, Hideki Nakasone, Hidenori Wada, Shunto Kawamura, Nozomu Yoshino, Junko Takeshita, Kazuki Yoshimura, Yukiko Misaki, Aki Tanihara, Yu Akahoshi and 6 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Ayumi GomyoDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Hideki NakasoneDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Hidenori WadaDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Shunto KawamuraDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Nozomu YoshinoDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Junko TakeshitaDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Kazuki YoshimuraDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Yukiko MisakiDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Aki TaniharaDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Yu AkahoshiDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Machiko KusudaDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Masaharu TamakiDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Koji KawamuraDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Shun-Ichi KimuraDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Shinichi KakoDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Yoshinobu KandaDivision of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
Jichi Medical University Saitama Medical Center · JPJichi Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autologous hematopoietic recovery after allogeneic hematopoietic cell transplantation (allo-HCT) is rare in patients who receive myeloablative conditioning (MAC). Autologous hematopoietic recovery suggests graft rejection, leading to concerns about subsequent disease relapse. We herein report a rare case of a patient with acute leukemia who experienced autologous hematopoietic recovery after cord blood transplantation (CBT) with total body irradiation-based MAC. Chromosomal abnormalities were repeatedly detected without any disease relapse for eight months. The accumulation of similar cases is required to accurately assess the incidence and clinical outcomes of autologous hematopoietic recovery after CBT with MAC.

Indexed as

AdultCord Blood Stem Cell TransplantationGraft RejectionGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansLeukemia, Myeloid, AcuteMaleMyeloablative AgonistsTransplantation ConditioningTransplantation, HomologousTreatment OutcomeMyeloablative Agonistsautologous hematopoietic recoverymyeloablative conditioning

Identifiers

PMID32536652
PMCPMC7644496
OpenAlexW3034970558

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.